The agency’s letter to the Marlborough-based medical device company's (Nasdaq: HOLX) CEO, Stephen MacMillan, which was made public on Tuesday, said the FDA found that the company’s BioZorb ...

Moderna Inc. entered the new year on the heels of a worsening stock performance in 2024. The Cambridge drugmaker’s stock dropped even further after lowering its expected revenue range for 2025 ...

MARLBOROUGH, Conn. (WTNH) — Multiple fire departments helped battle a house fire in Marlborough early Monday morning, officials said. Fire officials said crews arrived at the scene at around 5 a ...

MARLBOROUGH, CT (WFSB) - A firefighter was transported to a hospital during a house fire battle in Marlborough on Monday. The scene was on Jones Hollow Road. Fire officials said the fire broke out ...

Crews have responded to a house fire in Marlborough on Monday morning. The fire was reported around 5 a.m. at a home on Jones Hollow Road. Authorities have not released any details about the size ...

Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19 ...

Earlier this month, Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s lackluster vaccine sales in COVID-19 and respiratory ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...